You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Rear Vision Head Mounted Display

    SBC: ISEEYOU360 INC            Topic: AF203CSO1

    ISeeYou360 is an early stage start-up wearable technology company working on developing safety systems for the warfighter, public safety and civilian markets. Currently bootstrapped working with US manufacturing component providers Six-15 Technologies, we intend to integrate the ISeeYou360 helmet mounted device with multiple active systems such as 360 vehicle systems (eWindow360). ISeeYou360 is he ...

    SBIR Phase I 2021 Department of DefenseAir Force
  2. The Nomad Vehicle Barrier & Security Fence

    SBC: Redhawk Construction, Inc.            Topic: AF203CSO1

    The Nomad Vehicle Barrier is a collaborative partnership between the Nomad Security Fence System and the Cowboy Barrier. The purpose of the collaboration is to combine a mobile high-security fence with a mobile vehicle barrier. During the Nomad SBIR Phase I contract, multiple end-users specifically requested a vehicle barrier option. The Cowboy Barrier system is a natural integration with a ...

    SBIR Phase I 2021 Department of DefenseAir Force
  3. A Nanoporous Aerogel for Improvement of In-Ear Hearing Protection

    SBC: OTO-Biomechanics, LLC            Topic: AF21ATCSO1

    Despite the availability of active hearing protection devices (HPDs), noise-proof helmets, and earmuffs, passive in-ear HPDs are still widely used by military personnel in loud work environments and during operations due to their versatility and low economic cost. While these passive devices offer adequate sound pressure attenuation, an undesired effect persists known as the occlusion effect. Curr ...

    STTR Phase I 2021 Department of DefenseAir Force
  4. intelligent, reusable up to 10 day container system for transporting blood to and throughout the battlefield.

    SBC: MAXQ RESEARCH LLC            Topic: DHA211011

    Hemorrhage is the leading potentially preventable cause of battlefield mortality. Timely and balanced resuscitation with blood components lead to increased survival by achieving hemostasis as quickly as possible. However, transporting and maintaining blood inventory at far forward bases can be challenging. These products must be transported with proper cold chain maintenance in containers that can ...

    SBIR Phase I 2021 Department of DefenseDefense Health Agency
  5. Development of a commercial assay for the rapid and general detection of PFAS in environmental matrices (Phase I)

    SBC: WEAVER LABS LLC            Topic: R

    AbstractPolyfluoro- and perfluoroalkyl substances (PFAS) are a group of highly fluorinated alkanes. Members of this family are known to be persistent and bioaccumulative. PFAS are associated with unfavorable health outcomes in human and animal models. Several public health agencies as well as scientists have published articles that indicate the presence of PFAS in human blood, serum, milk, cord bl ...

    SBIR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health
  6. Crosslinkable Tissue Particles for Regenerating Craniofacial Bone in an Ovine Model

    SBC: Leefa Biotech LLC            Topic: NIDCR

    PROJECT SUMMARY The overall goal of this application is the translation of a new crosslinkable bone void filler that will allow surgeons to better heal patients after craniofacial bone loss. The bone void filler designed is unique in that it can be implanted as a paste then quickly transition to a solid after initiation with blue light. The ability to transition into a solid after placement is uni ...

    SBIR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health
  7. Novel Ophthalmic Product for Corneal Infections and Injuries

    SBC: BIOLYTX PHARMACEUTICALS CORP            Topic: NEI

    Biolytx Pharmaceuticals Corp. is developing a peptide, BP001, derived from the human endogenous host defense protein CAP37, as a novel multi-target ophthalmic product for corneal infections and injuries. The standard-of-care for corneal infections is topical administration of antibiotics that may be accompanied by topical steroids, to limit the destructive effect of the resulting corneal inflammat ...

    STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health
  8. Development of high affinity novel Fluor Mop adsorbent for the rapid removal of perfluorinated chemicals from groundwater

    SBC: WEAVER LABS LLC            Topic: R

    Perfluorinated alkyl substances (PFAS), nicknamed “Forever Chemicals”, are extensively used in industries and firefighting applications as a component of aqueous film forming foams (AFFFs). Because members of this class of chemicals are persistent, they are prevalent in nature and are detected across the globe in water, air, soil, plants, animals, and even in human milk and blood. They are tox ...

    SBIR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health
  9. A Novel Small Molecule for The Prevention and Treatment of Age-Related Macular Degeneration

    SBC: EXCITANT THERAPEUTICS LLC            Topic: NEI

    SUMMARY Age-related macular degeneration (AMD) is the leading cause of blindness in the elderly in the U.S. Wet AMD accounts for up to 90% of vision loss in AMD patients, which is characterized by choroidal neovascularization (CNV). Currently, no cure exists for AMD, and available drug therapies focus on intravitreal injection of anti- vascular endothelial growth factor (VEGF) agents. These anti-V ...

    SBIR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health
  10. Optimizing population health outcomes in diabetic retinopathy through personalized and scalable screening strategies

    SBC: RETINAL CARE INC            Topic: NEI

    Project Summary / Abstract According to the National Eye Institute (NEI), early detection and timely treatment can reduce the risk of severe vision loss from diabetic retinopathy (DR) by 95%. Yet, DR remains the leading cause of blindness among American adults. By 2030, 54.9 million Americans are expected to have diabetes. The prevalence of vision-threatening diabetic retinopathy (VTDR) among peop ...

    SBIR Phase II 2021 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government